INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 137 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,446,805 | -27.0% | 615,016 | -5.9% | 0.00% | -33.3% |
Q2 2023 | $26,643,613 | +6.5% | 653,350 | -2.6% | 0.00% | 0.0% |
Q1 2023 | $25,014,037 | +108092.2% | 671,132 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $23,120 | -99.9% | 662,617 | +3.4% | 0.00% | -40.0% |
Q3 2022 | $35,862,000 | +7.8% | 640,847 | -0.3% | 0.01% | 0.0% |
Q2 2022 | $33,253,000 | -27.1% | 642,464 | +2.3% | 0.01% | 0.0% |
Q1 2022 | $45,635,000 | -42.3% | 627,969 | -6.0% | 0.01% | -44.4% |
Q4 2021 | $79,028,000 | +19.3% | 668,367 | +35.4% | 0.01% | +12.5% |
Q3 2021 | $66,234,000 | -54.4% | 493,727 | -44.9% | 0.01% | -52.9% |
Q2 2021 | $145,164,000 | +100.5% | 896,577 | -0.6% | 0.02% | +70.0% |
Q1 2021 | $72,385,000 | +115.4% | 901,934 | +46.0% | 0.01% | +100.0% |
Q4 2020 | $33,610,000 | +263.2% | 617,824 | +44.3% | 0.01% | +150.0% |
Q3 2020 | $9,254,000 | +41.9% | 428,196 | +38.0% | 0.00% | +100.0% |
Q2 2020 | $6,522,000 | +138.5% | 310,281 | +38.8% | 0.00% | 0.0% |
Q1 2020 | $2,735,000 | +48.2% | 223,622 | +77.7% | 0.00% | – |
Q4 2019 | $1,846,000 | +992.3% | 125,815 | +892.6% | 0.00% | – |
Q3 2019 | $169,000 | +11.2% | 12,675 | +26.8% | 0.00% | – |
Q2 2019 | $152,000 | +10.1% | 10,000 | +23.4% | 0.00% | – |
Q1 2019 | $138,000 | +19.0% | 8,106 | -4.5% | 0.00% | – |
Q4 2018 | $116,000 | -47.3% | 8,487 | +10.3% | 0.00% | – |
Q3 2018 | $220,000 | +18.9% | 7,695 | +14.0% | 0.00% | – |
Q2 2018 | $185,000 | -68.5% | 6,748 | -75.8% | 0.00% | – |
Q1 2018 | $588,000 | +752.2% | 27,884 | +675.6% | 0.00% | – |
Q4 2017 | $69,000 | +46.8% | 3,595 | +8.9% | 0.00% | – |
Q1 2017 | $47,000 | -96.4% | 3,302 | -94.6% | 0.00% | – |
Q2 2016 | $1,301,000 | – | 60,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |